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tissue (WAT), brown adipose tissue (BAT), skeletal muscle, 
and pancreas ( 3–6 ). FGF21 expression in liver is under 
tight control by peroxisome proliferator-activated recep-
tor (PPAR)   ( 7–10 ). It is induced in the liver during fast-
ing and its expression induces a metabolic state that 
mimics long-term fasting. Thus, FGF21 is critical for the 
induction of hepatic fat oxidation, ketogenesis, and gluco-
neogenesis, which are metabolic processes critical for the 
adaptive metabolic response to starvation ( 11 ).  Fgf21 is 
also a target of the liver X receptor that represses its induc-
tion during fasting ( 12, 13 ). Signifi cantly, FGF21 extends 
life span in transgenic mice to a similar extent as dietary 
restriction ( 14 ). 
 A dietary amino acid imbalance alters metabolic path-
ways beyond protein homeostasis. GCN2-dependent inhi-
bition of fatty acid synthase (FASN) activity, expression of 
lipogenic genes in liver, and increased mobilization of 
lipid stores occur in response to leucine deprivation in 
mice ( 15 ). In addition, the following have been observed: 
increased expression of   -oxidation genes, decreased ex-
pression of lipogenic genes and activation of FASN in 
WAT, and increased expression of uncoupling protein 1 
( Ucp1 ) in BAT ( 16, 17 ). 
 Abstract  Lipogenic gene expression in liver is repressed in 
mice upon leucine deprivation. The hormone fi broblast 
growth factor 21 (FGF21), which is critical to the adaptive 
metabolic response to starvation, is also induced under 
amino acid deprivation. Upon leucine deprivation, we found 
that FGF21 is needed to repress expression of lipogenic 
genes in liver and white adipose tissue, and stimulate phos-
phorylation of hormone-sensitive lipase in white adipose tis-
sue. The increased expression of  Ucp1 in brown adipose 
tissue under these circumstances is also impaired in FGF21-
defi cient mice.  Our results demonstrate the important 
role of FGF21 in the regulation of lipid metabolism dur-
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 Amino acid starvation initiates a signal transduction cas-
cade, starting with the activation of the general control 
nonderepressible 2 (GCN2) kinase, phosphorylation of 
eukaryotic initiation factor 2 (eIF2), and increased synthe-
sis of activating transcription factor 4 (ATF4) ( 1 ). We have 
recently found that fi broblast growth factor 21 ( Fgf21 ) is a 
target gene for ATF4. Consequently, FGF21 is induced by 
amino acid deprivation both in mouse liver and HepG2 
cells as part of the transcriptional program initiated by in-
creased levels of ATF4 ( 2 ). 
 FGF21 is a member of the FGF family with endocrine 
properties. It is predominantly produced by the liver, but 
is also produced by other tissues such as white adipose 
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incubator, and cultures were replenished with fresh MEM me-
dium and serum for approximately 16 h prior to initiating all 
treatments to ensure that the cells were in the basal (“fed”) state. 
Amino acid deprivation was induced by transfer of cells to cul-
ture medium containing 2 mM histidinol (HisOH) for 8 h, which 
blocks charging of histidine onto the corresponding tRNA and 
thus mimics histidine deprivation and triggers activation of the 
AAR cascade ( 19 ). For mitogen-activated protein/ERK kinase 
(MEK) inhibition, the direct upstream kinases of ERK1/2, cells 
were treated with 30   M PD98059 (PD98) for approximately 16 h 
before harvesting. HisOH (H6647) and PD98059 (P215) were pur-
chased from Sigma-Aldrich (St. Louis, MO). Primary BAT adipo-
cytes were obtained and maintained as previously described ( 20 ). 
Mouse 3T3-L1 adipocytes were cultured and differentiated as de-
scribed previously ( 21 ). 
 Serum measurements.  Serum was obtained by centrifugation 
of clotted blood and stored at   80°C. A mouse FGF21 enzyme-
linked immunosorbent assay (ELISA) kit was obtained from Mil-
lipore for the quantifi cation of FGF21 in mouse serum. The assay 
was conducted according to the manufacturer’s protocol. Briefl y, 
a calibration curve was constructed by plotting the difference in 
absorbance values at 450 and 590 nm versus the FGF21 concen-
trations of the calibrators, and concentrations of unknown sam-
ples (performed in duplicate) were determined using this 
calibration curve ( 22 ). The Veterinary Service of Clinical Bio-
chemistry at the Universitat Autònoma de Barcelona determined 
blood biochemical parameters. 
 RNA isolation and relative quantitative RT-PCR.  Total RNA 
was extracted from the frozen tissues [liver, epididymal white adi-
pose tissue (eWAT), and BAT] or cells (3T3L1 and primary 
brown adipocytes) using TRI reagent solution (Ambion) fol-
lowed by DNase I treatment (Ambion) to eliminate genomic 
DNA contamination. To measure the relative mRNA levels, quan-
titative (q)RT-PCR was performed using TaqMan reagents. cDNA 
was synthesized from 1   g of total RNA by MLV reverse tran-
scriptase (Invitrogen) with random hexamers (Roche Diagnos-
tics) according to the manufacturer’s instructions. TaqMan Gene 
Expression Master Mix and TaqMan Gene Expression assays 
(Invitrogen/Applied Biosystems) were used for the PCR step. 
Amplifi cation and detection were performed using the Step-One 
Plus Real-Time PCR System. Each mRNA from a single sample 
was measured in duplicate, using 18S rRNA as an internal con-
trol. Results were obtained by the comparative threshold cycle 
(Ct) method and expressed as fold of the experimental control. 
 Protein extract preparation.  Whole-cell lysates from HepG2 cells 
were isolated using NP40 lysis buffer [50 mM Tris-HCl (pH 8), 
150 mM NaCl, 1% Nonidet P-40]. To obtain liver nuclear ex-
tracts, frozen liver was triturated within a mortar in liquid nitro-
gen and immediately homogenized with a Dounce homogenizer 
in 1 ml of HB buffer [15 mM Tris-HCl (pH 8), 15 mM NaCl, 
60 mM KCl, 0.5 mM EDTA], and centrifuged at 800  g for 5 min. The 
resulting pellet was resuspended in 100   l of HB buffer supple-
mented with 0.05% Triton X-100 (Sigma), and centrifuged for 
10 min at 1,000  g . Nuclear pellets were washed with 1 ml of HB buf-
fer supplemented with 0.05% Triton X-100 and 1 ml of HB buf-
fer. Nuclei were incubated at 4°C for 30 min in 50   l of HB buffer 
containing 360 mM KCl and centrifuged for 5 min at 10,000  g . 
The supernatant corresponding to the nuclear extract was col-
lected, frozen, and stored at   80°C. To obtain liver, WAT, and 
BAT total extracts, tissues were homogenized in RIPA buffer and 
centrifuged at 12,000  g for 15 min at 4°C. The supernatant was 
collected and frozen at   80°C until analysis. Protein concentra-
tion was assayed using Bio-Rad reagent. All of the buffers were 
 The coincidence between the metabolic response to es-
sential amino acid deprivation and to FGF21, the induc-
tion of  Fgf21 under amino acid deprivation ( 2 ), together 
with the repression of the transcription and maturation of 
sterol regulatory element binding protein 1c (SREBP1c) 
induced by FGF21 in HepG2 cells ( 18 ), led us to consider 
that FGF21 could be an important mediator between 
amino acid deprivation and lipid metabolism in liver, 
WAT, and BAT. 
 To investigate this hypothesis, we examined the re-
sponse of FGF21-defi cient mice to deprivation of the es-
sential amino acid leucine. As expected, we found a huge 
increase in  Fgf21 expression in the liver of wild-type (WT) 
animals, along with a repression of lipogenic genes after 7 
days of leucine deprivation. In this condition, FGF21-defi -
cient mice developed liver steatosis caused by unrepressed 
expression of lipogenic genes. In WAT, the expression of 
lipogenic genes was also repressed and the phosphoryla-
tion of hormone-sensitive lipase (HSL) was increased un-
der leucine deprivation. The absence of leucine also 
induced an increase in the expression of  Ucp1 and type 2 
deiodinase ( Dio2 ) in BAT. We found that all these effects 
in WAT and BAT were also impaired in FGF21-defi cient 
mice. Here, we show the involvement of FGF21 in the reg-
ulation of lipid metabolism during amino acid starvation, 
thus reinforcing its important role as an endocrine factor 
in coordinating energy homeostasis under a variety of nu-
tritional conditions. 
 MATERIALS AND METHODS 
 Animals and diets 
 Male WT and  Fgf21 -null mice (B6N; 129 S5-Fgf21tm1Lex/
Mmucd), obtained from the Mutant Mouse Regional Resource 
Center, were housed in a temperature-controlled room (22 ± 
1°C) on a 12/12 h light/dark cycle and were provided free access 
to commercial rodent chow and tap water prior to the experi-
ments. Control (nutritionally complete amino acid) and leucine-
defi cient [(  )leu] diets were obtained from Research Diets, Inc. 
(New Brunswick, NJ). All diets were isocaloric and composition-
ally the same in terms of carbohydrate and lipid components. At 
the beginning of the feeding experiment, 12–15 week old male 
mice were fi rst acclimated to the control diet for 7 days, and then 
randomly assigned to either the control diet group, with contin-
ued free access to the nutritionally complete diet, or the (  )leu 
diet group, with free access to the diet devoid of the essential 
amino acid leucine for 7 days. Food intake and body weight were 
recorded at least every 2 days. Animals were anesthetized by iso-
fl urane inhalation, and blood was collected from the heart for 
the assay described below. After euthanization, tissues were iso-
lated and immediately snap-frozen and stored at   80°C for fu-
ture analysis. The Animal Ethics Committee of the University of 
Barcelona approved these experiments. 
 Cell culture and treatment conditions 
 HepG2 cells were cultured in Eagle’s Minimal Essential Me-
dium (MEM) (GIBCO, Invitrogen) supplemented to contain 1× 
nonessential amino acids, 4 mM glutamine, 100   g/ml strepto-
mycin sulfate, 100 units/ml penicillin G, and 10% (v/v) fetal bo-
vine serum. Cells were maintained at 37°C in a 5% CO 2 /95% air 
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 Lipolysis assay.  Lipolysis assay was performed after 24 h 
treatment with FGF21 using the Free Glycerol Determination Kit 
(Sigma). 
 Data analysis/statistics.  All data are expressed as means ± 
SEM. Signifi cant differences were assessed by a two-tailed Stu-
dent’s  t -test.  P < 0.05 was considered statistically signifi cant.  a ,  P < 
0.05 versus control (Ctl) WT mice (or DMSO-treated HepG2 
cells);  b ,  P < 0.05 versus Ctl  Fgf21 -knockout (KO) mice;  c ,  P < 0.05 
versus (  )leu WT (or HisOH-treated HepG2 cells) (n = 6 per 
group of mice, or at least three independent experiments with 
HepG2 cells). 
 RESULTS 
 FGF21 gene expression is induced by leucine deprivation 
specifi cally in liver but not in BAT or WAT 
 According to our previously reported results ( 2 ), mice 
maintained on a (  )leu diet show a dramatic increase in 
FGF21 circulating levels ( Fig. 1A ). To check the origin of 
this circulating FGF21 we analyzed  Fgf21 gene expression 
in several tissues. Consistent with the liver as the main site 
of FGF21 production and release into the blood,  Fgf21 
mRNA levels in liver paralleled those in serum, whereas 
mRNA levels were unchanged in BAT and, unexpectedly, 
signifi cantly decreased in eWAT in WT mice maintained 
on a (  )leu diet ( Fig. 1B ). As expected,  Fgf21 mRNA lev-
els were undetectable in any analyzed tissue in the  Fgf21 -KO 
mice. In accordance with previous reports ( 23 ), the circu-
lating levels of FGF21 in KO mice were below the thresh-
old for correct quantifi cation . 
 FGF21 defi ciency signifi cantly attenuates weight loss 
under leucine deprivation 
 When fed a leucine-deprived diet, mice undergo rapid 
weight loss ( 16 ). The goal of the present study is to investi-
gate whether this phenomenon is FGF21 dependent. For 
this purpose, WT and  Fgf21 -KO mice were fed a control or 
(  )leu diet for 7 days. Together with total body weight 
supplemented with a mixture of protease inhibitors (Sigma-Al-
drich), 0.1 mM phenylmethylsulfonyl fl uoride (PMSF), and a 
phosphatase inhibitor cocktail (IPC3, Sigma-Aldrich). 
 Immunoblotting.  Total and nuclear proteins were resolved 
by SDS-polyacrylamide gel electrophoresis and transferred onto 
a Hybond-P PVDF membrane (Millipore). Membranes were 
blocked for 1 h at room temperature. The blots were then incu-
bated with primary antibody in blocking solution overnight at 
4°C. Antibodies were diluted according to the manufacturer’s 
instructions. The blots were washed three times and incubated 
with horseradish peroxidase-conjugated secondary antibody in 
blocking buffer for 2 h at room temperature. After three washes, 
the blots were developed using the EZ-ECL Chemiluminescence 
Detection Kit for HRP (Biological Industries). The quantifi ca-
tion of phosphorylation was performed by densitometry of phos-
phorylated protein normalized to total protein using Image J 
software. 
 Antibodies.  HSL (#4107), phospho HSL (#4126), ERK1/2 
(#4695), phospho-ERK1/2 (#4370), and phospho-p38 (#9211) 
antibodies were purchased from Cell Signaling Technology. 
ATF4 (sc-200), p38  /  (A-12, sc-7972), and SREBP1c (C-20, 
sc-36) antibodies were from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA); FASN (ab128870) antibody was from Abcam; 
acetyl-CoA carboxylase 1 (ACC1) (04-322) and phospho-ACC1 
(07-303) antibodies were from Millipore; actin antibody (A2066) 
was from Sigma-Aldrich; and tubulin antibody (#CP06) was from 
Calbiochem. 
 Histological examinations.  For the histological analysis, 
tissues (liver and eWAT) were fi xed in 10% formalin (Sigma-
Aldrich) and embedded in paraffi n. Then, 4   m thick sections 
were cut and stained with hematoxylin and eosin (H and E). 
Images were acquired using a Leica CTR 4000 microscope. 
Quantitative data were obtained using the IMAT program de-
veloped in the Science and Technology Center of the Univer-
sity of Barcelona. The selection of the test objects was 
performed according to color and choosing the same limits 
for binari zation for all images. Adipocyte size and lipid accumula-
tion were measured using at least three different randomly cho-
sen fi elds of eWAT and liver sections, respectively, from each 
mouse. 
 Fig.  1. FGF21 is differently regulated by leucine deprivation in liver and adipose tissues. A: Serum FGF21 
protein concentrations were measured by ELISA. B:  Fgf21 mRNA in BAT, eWAT, and liver was measured by 
qRT-PCR. Error bars represent the mean ± SEM.  a ,  P < 0.05 versus Ctl WT. 
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suggested that FGF21 stimulates lipolysis in WAT during 
normal feeding, but inhibits it during fasting ( 25 ). There-
fore, to examine the role of FGF21 in lipolysis, we evalu-
ated the mRNA levels of adipose triglyceride lipase ( Atgl ), 
 Hsl , and perilipin 1 ( Plin1 ), and the levels of phosphory-
lated HSL. We did not fi nd any statistically signifi cant 
changes in  Atgl ,  Hsl , or  Plin1 mRNA levels upon leucine 
deprivation ( Fig. 3B ). Consistent with changes in body 
weight, lack of FGF21 signifi cantly decreased levels of 
phosphorylated HSL in WAT under leucine deprivation 
( Fig. 3C ), which suggests that lipolysis was impaired in 
these mice. Despite the evidence of increased lipolysis un-
der leucine deprivation, levels of free fatty acids in serum 
were not signifi cantly altered in the conditions analyzed 
( Table 1 ), suggesting increased fatty acid utilization by 
other tissues. 
 FGF21 defi ciency prevents changes in liver and WAT 
in leucine-deprived mice 
 A link between FGF21 and SREBP1c during lipogene-
sis in cultured hepatocytes has recently been proposed 
( 18 ). As lipogenic genes are downregulated in the liver 
of mice deprived of leucine ( 15 ), we speculated that 
FGF21 might regulate their expression. To investigate 
this possibility, we examined the expression of genes in-
volved in the regulation of lipid metabolism in the liver 
loss ( Figs. 2A, B ), mice fed a leucine-deprived diet un-
dergo a fat mass loss, both epididymal and subcutaneous 
( Fig. 2D ). We found that these effects were partially 
blunted in  Fgf21 -KO mice ( Figs. 2A, B, D ), while the reduc-
tion in food intake caused by leucine deprivation (  30%) 
was unchanged between genotypes ( Fig. 2C ). 
 The reported observation that white adipocytes from 
FGF21 transgenic mice are substantially smaller than those 
from WT mice ( 8, 24 ) and that leucine deprivation de-
creased adipocyte volume ( 16 ), led us to examine whether 
this effect was FGF21 dependent. A histological analysis of 
eWAT ( Fig. 3A ) showed that leucine deprivation resulted 
in a reduction in adipocyte volume compared with mice 
fed a control diet. By contrast, the adipocyte volume was 
only slightly reduced in (  )leu-fed  Fgf21 -KO mice and re-
mained unchanged in  Fgf21 -KO mice on the control diet 
( Fig. 3A ). We note that other groups reported increased 
( 25 ) or decreased ( 26 ) adipocyte size in  Fgf21 -KO mice on 
regular diets. We have no explanation for these discrepan-
cies beyond potential minor differences in the composi-
tion of the diet. 
 Increased phosphorylation of HSL under leucine 
deprivation is FGF21 dependent 
 It has been previously described that leucine depri-
vation increases lipolysis in WAT ( 16 ). It has also been 
 Fig.  2. FGF21 is required for (  )leu diet effects on body weight without affecting food consumption. A: Body weight of mice fed with Ctl 
or (  )leu diet. The weight on the fi rst day was considered 100%. B: Body weight change (%) after 7 days of feeding the Ctl or (  )leu diet. 
C: Daily food intake. D: BAT, eWAT, and scWAT weight of mice fed with Ctl or (  )leu diet related to 100 mg of body weight. E: Liver weight 
of mice fed with Ctl or (  )leu diet related to 100 mg of body weight. Error bars represent the mean ± SEM.  a ,  P < 0.05 versus Ctl WT mice; 
 b ,  P < 0.05 versus Ctl FGF21-KO mice;  c ,  P < 0.05 versus (  )leu WT mice (n = 6/group). 
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[cluster of differentiation 36 ( Cd36 ) and  fatty acid bind-
ing protein 4 ( Fabp4 )] or oxidation [carnitine palmitoyl-
transferase 1a  ( Cpt1a )] was decreased in the absence of 
 Fgf21 . The analysis of FASN, SREBP1c, and ACC1 protein 
abundance showed a good correlation with the gene ex-
pression data ( Fig. 4B ). By contrast ACC1 phosphoryla-
tion was decreased under leucine deprivation in both 
WT and  Fgf21 -KO mice. 
of WT and  Fgf21 -KO mice maintained either on the con-
trol or (  )leu diet. As expected, levels of  Fasn ,  Srebp1c , 
and  Acc1 mRNA were signifi cantly decreased on the (  )
leu diet. However, in mice lacking FGF21, the reduced 
expression of  Fasn was statistically signifi cantly increased, 
and, although not statistically signifi cant, showed a ten-
dency to increase in both  Srebp1c and  Acc1 ( Fig. 4A ). The 
expression of other genes involved in fatty acid uptake 
 Fig.  3. The (  )leu diet effects on adipocyte size and lipid metabolism in WAT are FGF21 dependent. A: Representative H and E-stained 
eWAT sections from WT and FGF21-KO mice (×20 magnifi cation). Scale bar, 50   M. Adipocyte size (right panel) was measured as de-
scribed in Materials and Methods, using at least three different randomly chosen fi elds of eWAT sections from each mouse. B:  Atgl , Hsl ,  and 
Plin1 gene expression was measured by qRT-PCR in mouse eWAT. C: Phosphorylated HSL (P-HSL) and total HSL (t-HSL) protein levels 
were measured in WT and FGF21-KO eWAT homogenates by Western blot analysis. The bottom panel shows quantifi cation by densitometry 
of phosphorylated HSL normalized to total HSL using Image J software. Error bars represent the mean ± SEM.  a ,  P < 0.05 versus Ctl WT 
mice;  b ,  P < 0.05 versus Ctl FGF21-KO mice;  c ,  P < 0.05 versus (  )leu WT mice (n = 6/group). P-HSL, phosphorylated HSL. 
 TABLE 1. Serum measurements in mice maintained on different diets 
WT Ctl FGF21-KO Ctl WT leu(  ) FGF21-KO leu(  )
NEFA (nmol/l) 0.79 ± 0.11 1.05 ± 0.11 0.73 ± 0.09 0.82 ± 0.06
TG (mg/dl) 95.79 ± 7.18 153.73 ± 11.62 a 99.39 ± 15.36 186.08 ± 27.38 a , c 
Cholesterol (mg/dl) 101.13 ± 13,13 147.65 ± 4.21 a 96.40 ± 7.69 122.55 ± 3.08 b , c 
Glucose (mg/dl) 209.43 ± 10.45 212.90 ± 7.88 185.53 ± 14.87 187.02 ± 9.55
Glycerol (µmol/l) 393.50 ± 38.32 520.95 ± 23.10 a 313.93 ± 26.56 372.16 ± 19.99 b 
Insulin (µg/l) 1.26 ± 0.23 2.01 ± 0.52 0.41 ± 0.04 a 1.21 ± 0.20 c 
All data are expressed as means ± SEM. Signifi cant differences were assessed by a two-tailed Student’s  t -test. 
 P < 0.05 was considered statistically signifi cant. n = 6/group of mice. TG, triglycerides. 
 a P < 0.05 versus Ctl WT mice.
 b P < 0.05 versus Ctl FGF21-KO mice.
 c P < 0.05 versus (  )leu WT mice.
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a decrease in the expression of  Fasn , Srebp1c , and  Acc1 and 
also of  Atgl and  Plin ( Fig. 5D ). 
 The FGF21-dependent phenotype during leucine 
deprivation is not related with the mitogen-activated 
protein kinase ERK1/2 signaling pathway 
 As described, mitogen-activated protein kinase (MAPK) 
ERK1/2 signaling is required for the amino acid starvation 
response ( 27, 28 ). Accordingly, histidinol treatment of 
HepG2 cells, which blocks charging of histidine onto the 
corresponding tRNA and thus mimics histidine depriva-
tion, induced the phosphorylation of ERK1/2 ( Fig. 6A ). 
In addition, increased  FGF21 and asparagine synthetase 
( ASNS ), mRNA levels ( Fig. 6C ), as well as increased ATF4 
protein levels in HisOH-treated cells ( Fig. 6B ) were re-
duced in the presence of the MEK inhibitor PD98. In these 
cells,  FASN expression is opposed to that of  FGF21 ( Fig. 6D ), 
mimicking what we observed in leucine-deprived WT (high 
FGF21) or  Fgf21 -null mice ( Fig. 4A ). 
 As it has been described that exogenous FGF21 is able 
to induce ERK1/2 phosphorylation in the liver and WAT 
 Although liver triglyceride levels, measured by extrac-
tion and posterior quantifi cation, did not refl ect the ex-
pression pattern of the lipid synthesis genes, H and E 
staining revealed it. This suggested a decreased lipid ac-
cumulation under leucine deprivation in WT animals that 
does not seem to occur in the  Fgf21 -KO mice ( Fig. 4C ). 
 As expected, gene expression analysis in eWAT revealed 
that the mRNA levels of the lipogenic genes  Fasn ,  Srebp1c , 
and  Acc1 were also lower in this tissue in mice maintained 
on the (  )leu diet. These changes were blunted in the 
 Fgf21 -KO mice, particularly for  Fasn ( Fig. 5A ). The analysis 
of FASN protein abundance showed a good correlation 
with the gene expression data ( Fig. 5B ). 
 We have analyzed the expression of the FGF21-receptor 
complex   -Klotho and fi broblast growth factor receptor 1 
(FGFR1) in WAT. There was a signifi cant increase in both 
  -Klotho and  Fgfr1 mRNA levels induced by both  Fgf21 
knockout and leucine deprivation ( Figs. 5C ). 
 To further confi rm the results obtained in mice, we 
have analyzed the expression of lipogenic and lipolytic 
genes in 3T3L1 treated with FGF21. This treatment induced 
 Fig.  4. FGF21-KO liver has impaired lipid metabolism and lipid accumulation in response to leucine deprivation. A: Expression of genes 
related with lipid handling was measured by qRT-PCR in mouse liver. B: FASN , SREBP1c, phosphorylated ACC1 (P-ACC1), and total ACC1 
(t-ACC1) protein levels were detected by Western blot analysis in mouse liver. The bottom panel shows quantifi cation by densitometry of 
the immunoblotted proteins using Image J software. Error bars represent the mean ± SEM.  a ,  P < 0.05 versus Ctl WT mice;  b ,  P < 0.05 versus 
Ctl FGF21-KO mice;  c ,  P < 0.05 versus (  )leu WT mice (n = 6/group). C: Histological appearance and hepatic lipid accumulation of H and 
E liver staining of WT and FGF21-KO mice maintained either on a Ctl or a (  )leu diet. Representative H and E-stained hepatocytes are 
shown (×20 magnifi cation). Scale bar, 50   M . Lipid accumulation (right panel) was measured as described in Materials and Methods, using 
at least three different randomly chosen fi elds of liver sections from each mouse. Acadm, medium-chain acyl-CoA dehydrogenase; Acadl, 
long-chain acyl-CoA dehydrogenase; Acox, acetyl-CoA oxidase; Lpl, lipoprotein lipase; Scd1, stearoyl-CoA desaturase 1. 
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BAT of WT mice . These changes were blocked in  Fgf21 -KO 
mice ( Fig. 7A ). Because UCP1 expression is related to en-
ergy expenditure, the absence of induction of  Ucp1 in 
 Fgf21 -KO mice under leucine deprivation may contribute 
to the decrease in weight loss observed under these cir-
cumstances. mRNA levels of  Pgc1  , which regulates the 
expression of UCP1 ( 32 ), were also increased. However, 
they did not differ between WT and  Fgf21 -KO mice under 
either control or (  )leu diet conditions ( Fig. 7B ). The 
same pattern as for  Ppar  and  Pgc1  was observed for  Adrb3 
mRNA levels ( Fig. 7C ). We tested the possibility that the 
activation of p38 MAPK by the   3-adrenergic receptor 
(  3AR) participated in the induction of the  Ucp1 gene in 
BAT under this situation. However, although p38 phos-
phorylation, but not PKA activity, is induced in primary 
brown adipocytes treated with recombinant FGF21 (data 
not shown), phosphorylated p38 levels remained un-
changed between diets and genotypes in BAT ( Fig. 7C ). 
 We have also analyzed the expression of lipogenic and 
lipolytic genes and glycerol release in primary brown adi-
pocytes treated with FGF21. This treatment decreased the 
expression of  Fasn and increased glycerol release with-
out signifi cant changes in the expression of  Atgl and  Plin 
of acutely treated mice ( 29 ); we checked ERK1/2 phos-
phorylation in leucine-deprived WT and FGF21-null mice. 
Effectively, ERK1/2 phosphorylation was induced in the 
liver of leucine-deprived mice, although there were no dif-
ferences between genotypes ( Fig. 6E ). Accordingly, the 
amino acid starvation response program was correctly ini-
tiated in  Fgf21 -KO mice, as shown by the increased levels 
of ATF4 protein and  Asns , a prototypical ATF4 target gene, 
mRNA levels ( Fig. 6F ). Moreover, despite the fact that 
FGF21 serum levels are highly increased in leucine-de-
prived mice ( Fig. 1A ), ERK1/2 phosphorylation is not 
modifi ed in WAT ( Fig. 6G ). 
 FGF21 defi ciency prevents increases in BAT 
activation in leucine-deprived mice 
 Thermogenesis in BAT is mediated by the upregulation 
of UCP1 ( 30 ). It has been proposed that the induction of 
FGF21 production by the liver mediates direct activation 
of brown fat thermogenesis during the fetal-to-neonatal 
transition ( 20 ). FGF21 also regulates PPAR  coactivator 1 
(PGC1)   and browning of WAT in adaptive thermogen-
esis ( 31 ). Consistent with previous results ( 16 ), leucine de-
privation increased levels of  Ucp1 and  Dio2 mRNAs in the 
 Fig.  5. FGF21-KO eWAT has altered lipogenic pathway in response to leucine deprivation. A:  Fasn ,  Srebp1c , and  Acc1 gene expression was 
measured by qRT-PCR in mouse eWAT. B: FASN protein levels were detected by Western blot analysis in mouse liver. The bottom panel 
shows quantifi cation by densitometry of the immunoblotted proteins using Image J software. Error bars represent the mean ± SEM.  a ,  P < 
0.05 versus Ctl WT mice;  b ,  P < 0.05 versus Ctl FGF21-KO mice;  c ,  P < 0.05 versus (  )leu WT mice (n = 6/group). C:  FgfR1 and   -Klotho 
gene expression was measured by qRT-PCR in mouse eWAT. D: The expression of genes related with lipid metabolism pathways was mea-
sured by qRT-PCR in 3T3L1 adipocytes treated with recombinant FGF21 (100 nM) for 24 h. Error bars represent the mean ± SEM.  a ,  P < 
0.05 versus Ctl WT mice;  b ,  P < 0.05 versus Ctl FGF21-KO mice;  c ,  P < 0.05 versus (  )leu WT mice (n = 6/group). 
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in liver but not in BAT or WAT where they were not 
affected or even downregulated. 
 We have seen that FGF21 defi ciency signifi cantly attenu-
ates weight loss under leucine deprivation; although the 
established reduction in food intake induced by a leucine-
deprived diet was not changed by the absence of FGF21. 
This means that FGF21 is in part responsible for the loss of 
weight under amino acid deprivation, independently of 
food intake . Consistent with our observation, previous 
studies have shown that FGF21 transgenic mice are resis-
tant to diet-induced obesity (DIO) and that FGF21 treat-
ment induced weight loss in genetically obese (ob/ob) 
mice ( 24, 33, 34 ). 
 It has been shown that white adipocytes from FGF21 
transgenic mice are substantially smaller than those from 
WT mice ( 8, 24 ). Here, we demonstrate that the reduction 
( Fig. 7E, F ). Accordingly, mRNA levels of  Hsl and  Atgl as 
well as HSL phosphorylation did not change in BAT of 
 Fgf21 -defi cient mice ( Fig. 7B, D ). 
 DISCUSSION 
 We have previously shown that leucine deprivation sig-
nifi cantly increased FGF21 hepatic expression and serum 
protein levels ( 2 ), suggesting an important role of this 
hormone in the amino acid starvation phenotype. In the 
current study, we demonstrate that in response to leucine 
deprivation, weight loss, downregulation of liver and WAT 
key lipogenic genes, as well as BAT activation are partly 
FGF21 dependent. Our results show that the FGF21 serum 
levels positively correlate with the mRNA levels measured 
 Fig.  6. Activation of the MEK/ERK pathway in the liver by leucine deprivation is independent of FGF21. HepG2 cells were incubated for 
8 h with HisOH (2 mM) and the MEK inihibitor PD98 (30   M), when indicated. Phosphorylation of ERK1/2 (A) and ATF4 protein levels 
(B) were analyzed by Western blot in total and nuclear HepG2 extracts, respectively. mRNA levels for  FGF21 ,  ASNS (C), and  FASN (D) were 
analyzed by qRT-PCR. E: Phosphorylated ERK1/2 (P-ERK1/2) and total ERK1/2 (t-ERK1/2) levels were measured in liver extracts of WT 
and FGF21-KO mice by Western blot analysis. The right panel shows quantifi cation by densitometry of phosphorylated ERK1/2 normalized 
to total ERK1/2 using Image J software. F:  Asns and  Atf4 mRNA levels and nuclear ATF4 protein levels (insert), were measured in FGF21-KO 
mouse liver by qRT-PCR and Western blot, respectively. Actin was used as a loading control. A representative blot is shown. G: Phosphory-
lated and total ERK1/2 levels were measured in WT mouse eWAT homogenates by Western blot analysis. The right panel shows quantifi ca-
tion by densitometry of phosphorylated ERK1/2 normalized to total ERK1/2 using Image J software. Error bars represent the mean ± SEM. 
 a ,  P < 0.05 versus Ctl WT mice;  b ,  P < 0.05 versus Ctl FGF21-KO mice;  c ,  P < 0.05 versus (  )leu WT mice (n = 6/group). 
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 Fig.  7. FGF21 is required for inducing BAT activation during amino acid deprivation. A:  Ucp1 and  Dio2 gene expression was measured by 
qRT-PCR in mouse BAT. B: The expression of genes related with lipid metabolism was measured by qRT-PCR in mouse BAT. C: Phosphory-
lated p38 MAPK (P-p38 MAPK ) and total p38 MAPK (t-p38 MAPK) levels were measured in WT and FGF21-KO mouse liver extracts by 
Western blot analysis. The right panel shows quantifi cation by densitometry of phosphorylated p38 MAPK normalized to total p38 MAPK 
using Image J software. D: Phosphorylated and total HSL protein levels were measured in WT and FGF21-KO eWAT homogenates by West-
ern blot analysis. The right panel shows quantifi cation by densitometry of phosphorylated HSL normalized to total HSL, using Image J 
software. A representative blot is shown. E:  Fasn, Srebp1c, Atgl and  Plin1 gene expression was measured by qRT-PCR in differentiated primary 
BAT treated with FGF21 (50nM) for 24h. F: Glycerol release in differentiated primary BAT treated with FGF21 (5nM and 50nM) for 24h. 
Error bars represent the mean ± standard error of the mean (SEM). Error bars represent the mean ± SEM. A representative blot is shown. 
 a ,  P < 0.05 versus Ctl WT mice;  b ,  P < 0.05 versus Ctl FGF21-KO mice;  c ,  P < 0.05 versus (  )leu WT mice (n = 6/group). 
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its origin and other factors, which may refl ect the meta-
bolic state and the energy requirements of the organism. 
 An inhibitory action in the lipid synthesis had been al-
ready described for FGF21 ( 36 ). It was demonstrated that 
the reduction of hepatic triglyceride levels was associated 
with FGF21 inhibition of nuclear sterol regulatory element 
binding protein 1c ( Srebp1c ) and the expression of an ex-
tended array of genes involved in fatty acid and triglycer-
ide synthesis. Accordingly, in liver, we have seen that the 
expected reduction in the mRNA levels of  Srebp1c ,  Fasn , and 
 Acc1 by (  )leu diet was not observed in  Fgf21 -KO mice. 
We have also seen a direct effect in lipogenic gene expres-
sion in both 3T3L1 cells and primary brown adipocytes 
treated with recombinant FGF21. 
 The induction, in liver from  Fgf21 -KO mice, of  Asns ex-
pression, for which the gene product catalyzes the glu-
tamine and ATP-dependent conversion of aspartic acid to 
asparagine, suggests that FGF21 is not involved in the con-
trol of amino acid metabolism under amino acid starva-
tion. We have also observed that contrary to the exogenous 
FGF21 induction of ERK1/2 phosphorylation in the liver 
and WAT of acutely treated mice ( 29 ), the FGF21-depen-
dent phenotype in leucine deprivation is unexpectedly 
not related with the MAPK ERK1/2 signaling pathway 
both in liver and WAT. 
 BAT is a major site of adaptive thermogenesis, and it is 
used to preserve both thermal and caloric homeostasis in re-
sponse to environmental temperature or diet ( 37 ).  Fgf21 -KO 
mice under leucine deprivation exhibited decreased induc-
tion of genes defi ning BAT identity (i.e.,  Ucp1 and  Dio2 ), 
while its transcriptional regulators  Pgc1  and  Ppar  were 
identically induced in both WT and  Fgf21 -KO mice. Increased 
 Ucp1 expression may be regulated by the sympathetic ner-
vous system through the activation of   -adrenergic receptors. 
We found that the mRNA expression of  Adrb3 was induced 
by leucine deprivation in BAT, although there were no sig-
nifi cant changes between genotypes. The   3AR stimulates 
p38 MAPK, which is required for the   AR-dependent in-
crease in  Ucp1 expression in brown adipocytes ( 38 ). Never-
theless, p38 phosphorylation levels were not affected by 
leucine deprivation compared with control, both in the WT 
in the adipocyte volume that occurs under leucine depri-
vation depends on the increased FGF21 expression and 
secretion that takes place under this diet. 
 We have found that the levels of phosphorylated (P)-
HSL were increased upon (  )leu feeding in eWAT, as it 
was described in ( 16 ), so activation of the HSL protein 
probably allowed increased lipolysis. Interestingly, our re-
sults show that lack of FGF21 signifi cantly decreases phos-
phorylated HSL levels in the eWAT of (  )leu-fed mice, 
suggesting an important role of FGF21 action on leucine 
deprivation-induced lipolysis. 
 The analysis of blood biochemical parameters, however, 
did not show signifi cant changes in NEFA levels, likely due 
to increased fatty acid utilization by other tissues. We as-
sume that there is an increased glucagon signaling under 
leucine deprivation, indicated by the increased PKA-de-
pendent HSL Ser660 phosphorylation in WAT. Addition-
ally, a reduction in insulin levels under leucine deprivation 
is observed in WT but not in KO mice; these changes are 
well correlated with the differences observed in body 
weight and fat mass. 
 We have also examined whether the impaired reduction 
in body weight observed in  Fgf21 -KO mice under leucine 
deprivation was not only related to lipolysis in WAT, but 
also to other factors that infl uence adipose tissue mass as 
lipogenesis. We have observed a signifi cant reduction in 
 Fasn mRNA levels in eWAT upon (  )leu feeding that was 
totally blocked in  Fgf21 -KO mice.  Srebp1c and  Acc1 mRNA 
levels presented the same pattern, although with distinct 
statistical signifi cances. The endocrine effect of FGF21 on 
WAT under leucine deprivation that we observe here is 
different from the recently described autocrine effect on 
this tissue in a fed state, in which FGF21 induces lipogen-
esis through the regulation of PPAR  activity ( 26 ). The 
decreased  Fgf21 expression in WAT under leucine depri-
vation also contrasts with its observed induction after one 
day of fasting ( 35 ). FGF21 administration to DIO mice 
leads to a dramatic decrease in the WAT  Fgf21 transcript. 
However, controversially, it induces an increase in the ex-
pression of adipogenic genes ( 33 ). It seems, therefore, 
that the response to increased levels of FGF21 depends on 
 Fig.  8. Working model of the FGF21 regulatory 
pathway under leucine deprivation. 
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and  Fgf21 -KO mice. One of the best-known inducers of BAT 
and its function is norepinephrine ( 39 ), which has also been 
shown to be induced in leucine-deprived mice ( 16 ). These 
fi ndings raise the possibility that FGF21 might induce  Ucp1 
(and also  Dio2 ) through an indirect mechanism involving 
the central nervous system. Of interest, it has been recently 
proposed that increased expression of FGF21 secreted from 
liver enters the brain and stimulates the hypothalamic-pitu-
itary-adrenal axis ( 40 ). However, a more extensive analysis of 
other candidate factors should be performed in the future, 
and further investigation will be required to determine the 
exact mechanism by which FGF21 induces BAT activation. 
 In summary, we found that FGF21 is an important fac-
tor, although not the only one, in mediating the changes 
in lipid metabolism observed upon leucine deprivation 
( Fig. 8 ). We have shown that  Fgf21 -defi cient mice under 
these circumstances showed unrepressed lipogenesis in 
liver and WAT, decreased phosphorylation of HSL in WAT 
indicating impaired lipolysis, and impaired induction of 
 Ucp1 expression in BAT. Thus, our results suggest that 
FGF21 plays an important role in the regulation of lipid 
metabolism during amino acid starvation. 
 While this work was under revision, a study was published 
( 41 ) that showed the Atf4-dependent induction of FGF21 in 
mice with autophagy defi ciency in skeletal muscle or liver. 
As a result of this induction, these mice are protected from 
diet-induced obesity and insulin resistance. In the supple-
mentary results of this paper, the authors confi rm that the 
ATF4-FGF21 axis also has a physiologically relevant role un-
der conditions of leucine deprivation. In agreement with 
our results, they also show how the effects of leucine depri-
vation on body weight, fat weight, and blood glucose are 
partially diminished in  Fgf21 -KO mice.  
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